Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03804853 · ClinicalTrials.gov registry record · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
A NA study of Shoulder Osteoarthritis, sponsored by HealthPartners Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT03804853: Recruiting NA study of Shoulder Osteoarthritis, sponsored by HealthPartners Institute.
NCT03804853 is a NA study of Shoulder Osteoarthritis that is actively recruiting participants, run by HealthPartners Institute. The registered enrollment target is 74 participants, below the 197-participant average among 9 other Shoulder Osteoarthritis trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03804853, a NA study of Shoulder Osteoarthritis, is actively recruiting participants, sponsored by HealthPartners Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
Reverse total shoulder arthroplasty (RTSA) has been successful in patients with rotator cuff arthropathy, proximal humerus fractures, failed primary total shoulder arthroplasty or failed hemiarthroplasty, and massive irreparable rotator cuff tear. Patients who undergo an RTSA report pain relief and functional range of motion. It has been more than 20 years since the advent of the RTSA construct but an immediate post-operative rehabilitation with active shoulder range of motion has not been prospectively studied in comparison to the traditional post-operative rehabilitation highlighted by Boudreau et al.12 Investigators plan to prospectively follow our patients following RTSA undergoing an immediate active shoulder rehabilitation (IASR) vs traditional rehabilitation in a randomized controlled fashion. Investigators plan to document clinical outcomes, complications and cost effectiveness out to 1 year. The study will hopefully fulfill the Triple Aim model for HealthPartners by improving the health of the population, improve the experience of each individual, and make healthcare affordable by decreasing the total cost of care.
Primary Outcome
1\. American Shoulder and Elbow score (ASES) is a scale that measures shoulder pain and function with 11 items, one item for pain and 10 items for function. The score for each subscale is out of 50 (0-50), with a higher score indicating a better outcome. The total score is a sum of both subscales, ranging between 0-100, using the following formula, Total score = ((10 - VAS pain) × 5) + (5/3 × sum of function items).
Conditions Studied
Interventions
- OTHER Rehabilitiation
Study Locations (1)
Minnesota
- TRIA Orthopaedic Center - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2018-12-12 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT03804853 shows while recruiting
NCT03804853 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 197-participant average among 9 other Shoulder Osteoarthritis trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Shoulder Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Rehabilitiation is the first listed.
NCT03804853 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03804853 about?
NCT03804853 is a clinical study titled "Rehabilitation Following Reverse Total Shoulder Arthroplasty". Reverse total shoulder arthroplasty (RTSA) has been successful in patients with rotator cuff arthropathy, proximal humerus fractures, failed primary total shoulder arthroplasty or failed hemiarthroplasty, and massive irreparable rotator cuff tear. Patients who undergo an RTSA report pain relief and ...
What is the current status of trial NCT03804853?
This trial is currently recruiting. It is a NA study. The enrollment target is 74 participants. The study started on 2018-12-12. Estimated completion is 2026-12-31.
What conditions does trial NCT03804853 study?
This clinical trial studies the following conditions: Shoulder Osteoarthritis.
What interventions are being tested in trial NCT03804853?
The interventions under investigation include: Rehabilitiation (OTHER).
Who is sponsoring clinical trial NCT03804853?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03804853 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shoulder Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03804853's enrollment target sits among peer trials
74 9th of 9 higher than 1 of 9 other Shoulder Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Shoulder Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Zimmer Biomet Shoulder Arthroplasty PMCF
RECRUITING · NA
-
Sling vs No Sling After Reverse Total Shoulder Arthroplasty
ACTIVE NOT RECRUITING · NA
-
Local Infiltration Analgesia Vs. Interscalene Block in Total Shoulder Arthorplasty
COMPLETED · NA
-
AETOS Shoulder System
RECRUITING
-
PRP for Glenohumeral Osteoarthritis
RECRUITING · Phase 4
-
CBD for Pain Following Orthopedic Shoulder Surgery
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
- NCT05057702 · 74 participants · NA
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI